title: High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
authors.affiliation: Division of Hematology/Oncology University of California, San Francisco, USA.
authors.forename: G A
authors.initials: GA
authors.lastname: Smith
authors.forename: I C
authors.initials: IC
authors.lastname: Henderson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000191:economics; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D012189:Retrospective Studies; D014182:Transplantation, Autologous